References
- Postow M. Wolchok J. Toxicities associated with checkpoint inhibitor immunotherapy. In: Post T, ed. Waltham, MA: UpToDate; 2016.
- Papavasileiou E, Prasad S, Freitag SK, Sobrin L, Lobo AM. Ipilimumab - induced ocular and orbital inflammation. A case series and review of the literature. Ocul Immunol Inflamm 2016;24(2):140–146.
- Carrera W, Baartman BJ, Kosmorsky G. A case report of drug-induced myopathy involving extraocular muscles after combination therapy with tremelimumab and durvalumab for non-small cell lung cancer. J Neuro-Ophthalmol 2017;41(3):140–143. doi:10.1080/01658107.2017.1291686.
- Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol 2015;181(2):191–206. doi:10.1111/cei.12641.